Cipla, Glenmark recall drugs in US due to manufacturing issues
Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues.
Stay updated with breaking news from Ipratropium Bromide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues.
International Business News: NEW DELHI: Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regu.
According to the latest Enforcement Report issued by the USFDA, a New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. - Newsx
Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator.